When was Sealonix founded?

Sealonix was founded in 2023 and raised its 1st funding round within a year of its incorporation.

Where is Sealonix located?

Sealonix is headquartered in Bedford, United States.

Who is the current CEO of Sealonix?

Amar Sawhney of Sealonix. They have also founded 1 company.

Is Sealonix a funded company?

Sealonix is a funded company, having raised a total of $20M across 2 funding rounds to date. The company's 1st funding round was a $***** Series A round, raised on May 12, 2023.

When was the latest funding round of Sealonix?

Sealonix's latest funding was a $***** Conventional Debt round on May 23, 2023, with participation from 0 investor. Its primary sector is Surgical Instruments. In United States, the Surgical Instruments sector has seen $185M in funding in 2026 to date.

Where does Sealonix rank among its competitors?

Sealonix ranks 9th amongst 21 active competitors, of which 10 are funded. It stands 4th in terms of total funding among its competitors. The most recent competitor to raise funding was TYBR Health, which secured $30M in Jul, 2026.

Who are the top competitors of Sealonix?

Sealonix's top competitors include TYBR Health, Cousin Surgery and Neomend. Among them, TYBR Health secured the most recent funding round in July, 2026.

Sealonix - 2026 Company Profile, Team, Funding & Competitors

Company Details

Developer of hemostatic sealants for surgeries. It offers a sealant patch that provides rapid hemostasis for abdominopelvic and orthopedic procedures.

Key Metrics

Founded Year

2023

Location

Bedford, United States

Stage

Series A

Total Funding

$20M in 2 rounds

Latest Funding Round

Conventional Debt, May 23, 2023, $*****

Investors

Excelestar Ventures & 5 more

Ranked

9^th among 21 active competitors

Similar Companies

TYBR Health & 25 more

View Sealonix's full profile

Sealonix is associated with 1 legal entity given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Sealonix, Inc CIN: 921509270 , United States, Active	Dec 31, 2022	-	-	-

Sealonix has raised a total funding of $20M over 2 rounds. Its first funding round was on May 12, 2023. Sealonix has 6 institutional investors.

Here is the list of recent funding rounds of Sealonix:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 23, 2023	1258722	Conventional Debt	4298410	2084728	3953866	7916926
May 12, 2023	4742355	Series A	9803786	6959127	Excelestar Ventures	AMED Ventures & 4 more

Access funding benchmarks and valuations. Sign up today!

View details of Sealonix's funding rounds and investors

The founders of Sealonix is Amar Sawhney. Amar Sawhney is the CEO of Sealonix.

Here are the details of Sealonix's key team members:

Amar Sawhney: Founder & CEO of Sealonix.
Contact Info: 1 email address

View details of Sealonix's Founder profiles and Board Members

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Sealonix include TYBR Health, Cousin Surgery and Neomend. Here is the list of Top 10 competitors of Sealonix, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	TYBR Health 2020, Houston (United States), Series A	Provider of regenrative medicine for post surgical scarring	$38.4M	Vensana Capital, Mutual Capital Partners & 4 others	55/100
2nd	Cousin Surgery 1848, Wervicq Sud (France), Unfunded	Manufacturer of implantable textile medical devices for spine and visceral surgery. It develops innovative implants to advance visceral and spine surgery, focusing on preserving mobility and reducing post-operative pain. The company collaborates closely with surgeons and utilizes unique expertise in implantable textiles. Its product portfolio includes solutions for various surgical specialties, such as orthopedics, uro-gynecology, and bariatric surgery, along with adhesion prevention and hemostasis products. The company also offers subcontracting services and technological support.	-	Turenne Groupe, Nord Capital Partenaires	45/100
3rd	Neomend 1999, Irvine (United States), Acquired	Provider of air leak sealant for thoracic surgery	$38.8M	Vivo Capital, Blackstone & 4 others	43/100
4th	Sylke 2023, La Jolla (United States), Series B	Provider of medical device company	$15.5M	Vaark	40/100
5th	Tissuemed 1985, Leeds (United Kingdom), Acqui-Hired	Bioadhesive films to prevent body fluid and air leakage during surgery	$12.7M	Saints Capital, Shackleton Ventures & 5 others	39/100
6th	GATT Technologies BV 2011, Nijmegen (Netherlands), Series B	Polymer-based General Adhesive Tissue Tape	$11.4M	EIC Fund, Johnson & Johnson Innovation & 3 others	38/100
7th	BioDevek 2014, Boston (United States), Funding Raised	Developer of next generation of surgical sealant solutions	-	MedTech Innovator, HHS & 1 others	38/100
8th	Clozex 2003, Wellesley (United States), Series A	Innovative skin closure devices for advanced wound care and surgical solutions	$4.48M	-	36/100
9th	Sealonix 2023, Bedford (United States), Series A	Developer of hemostatic sealants for surgeries	$20M	AMED Ventures, Excelestar Ventures & 4 others	36/100
10th	Cohera Medical 2006, Pittsburgh (United States), Deadpooled	Developer of surgical adhesives and sealants	$136M	KKR, H.I.G. Private Equity & 5 others	35/100